SB 202026

Known as: SB-202026 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-1999
01219971999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
We have investigated the pharmacology of the functionally selective muscarinic M1 receptor partial agonist, sabcomeline [SB… (More)
Is this relevant?
1999
1999
After S-AMPA (8.0 mM) lesions to the nucleus basalis and medial septal regions, at the source of the cortical and hippocampal… (More)
Is this relevant?
1998
1998
1. Sabcomeline (SB-202026, 0.03 mg kg(-1), p.o.), a potent and functionally selective M1 receptor partial agonist, caused a… (More)
Is this relevant?
1998
1998
 Sabcomeline, (SB-202026 [R-(Z)-α-(methoxyimino)-1-azabicyclo [2.2.2] octane-3-acetonitrile]), a functionally selective… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 5
Is this relevant?
1997
1997
Loss of cholinergic function is believed to be implicated in the cognitive decline associated with senile dementia of the… (More)
Is this relevant?